Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Jazz Pharmaceuticals logo — Identifying, developing and commercializing meaningful produ...

Jazz Pharmaceuticals

Identifying, developing and commercializing meaningful products that address unmet medical needs

Founded 2003 Ireland Ireland 3640 employees IPO Total: $1.34B Biotechnology, Health Care +1

General Information

Company Name Jazz Pharmaceuticals
Founded Year 2003
Location Ireland Ireland
Founders / Decision Makers
Team member Team member
Employees 3640
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage IPO
Business Model B2B, B2C, B2D
Revenue Model Product Sales, Licensing
Social

BounceWatch is an independent company data service, not affiliated with Jazz Pharmaceuticals. To contact Jazz Pharmaceuticals, visit jazzpharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Jazz Pharmaceuticals compare?

A PDF of Jazz Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Jazz Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Jazz Pharmaceuticals

Jazz Pharmaceuticals, founded in 2003, is a global biopharmaceutical company headquartered in Ireland. The company is committed to transforming the lives of patients by developing life-changing medicines for serious diseases, especially those with limited treatment options. With a significant corporate presence in the US and England, Jazz Pharmaceuticals operates manufacturing facilities in Ireland, England, and Italy.

The company's ethos centers around its core values: integrity, collaboration, passion, innovation, and pursuit of excellence. This collaborative culture supports a diverse team of experts, scientists, and professionals dedicated to bringing novel medicines to patients with critical unmet needs.

Jazz Pharmaceuticals recently secured an $850.00 million Post-IPO Debt investment on 01 September 2024, indicating strong investor confidence and a bolstered capacity for further innovation and expansion in the biopharmaceutical field.

Business keywords: biopharmaceutical, neurology, psychiatry, rare diseases, innovation, sleep disorders, oncology, hematology, metabolic diseases, extended-release formulations, selective serotonin reuptake inhibitors, corporate culture, unmet medical needs

Services & Products

life-changing medicines development
clinical trial management
patient support programs
corporate partnerships development
medical education and fellowships

Target Customers

patients with rare diseases healthcare professionals biopharmaceutical investors pharmaceutical partners caregivers and families affected by rare diseases

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Debt $850.00M -
01 Sep 2024
Merger Undisclosed 1
Azur Pharma
01 Jan 2012
Post-IPO Debt $120.00M -
01 Dec 2009
Post-IPO Equity $7.00M 1
Longitude Capital
Longitude Capital
01 Jul 2009
IPO $108.00M -
01 May 2007
Series B $250.00M 8
Prospect Venture Partners Adams Street Partners Versant Ventures
Prospect Venture Partners, Adams Street Partners +6
01 Mar 2004
Series A $7.10M 1
Versant Ventures
Versant Ventures
01 Oct 2003

Jazz Pharmaceuticals Alternatives & Competitors

View All Alternatives
Jazz Pharmaceuticals vs
Ultragenyx
Ultragenyx United States

Going Beyond Every Day

Post-IPO Equity
1535 employees
Biotechnology, Health Care
Compare Jazz Pharmaceuticals vs Ultragenyx
Jazz Pharmaceuticals vs
RELIEF THERAPEUTICS Holding SA
RELIEF THERAPEUTICS Holding SA Switzerland

Providing relief to patients with unmet medical needs in select specialty and rare diseases.

Post-IPO Equity
9 employees
Biotechnology, Pharmaceutical
Compare Jazz Pharmaceuticals vs RELIEF THERAPEUTICS Holding SA
Jazz Pharmaceuticals vs
AMO Pharma LTD
AMO Pharma LTD United States

AMO Pharma is working to develop novel therapeutics for rare genetic neurodevelopmental disorders

Series A
12 employees
Biotechnology, Health Care
View all alternatives

FAQ About Jazz Pharmaceuticals

Identifying, developing and commercializing meaningful products that address unmet medical needs
Jazz Pharmaceuticals was founded in 2003.
Jazz Pharmaceuticals is headquartered in Ireland.
Jazz Pharmaceuticals operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on biopharmaceutical, neurology, psychiatry and rare diseases. Its customers include patients with rare diseases, healthcare professionals and biopharmaceutical investors.
Jazz Pharmaceuticals has a B2B, B2C and B2D business model. Its revenue comes from Product Sales and Licensing.
Jazz Pharmaceuticals has approximately 3640 employees.
Jazz Pharmaceuticals has completed 7 funding rounds, raising a total of $1.34B. The latest funding stage is IPO.
Jazz Pharmaceuticals offers: life-changing medicines development, clinical trial management, patient support programs, corporate partnerships development, medical education and fellowships.
Top alternatives and competitors to Jazz Pharmaceuticals include Ultragenyx, RELIEF THERAPEUTICS Holding SA, AMO Pharma LTD, Takeda, Sompharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Jazz Pharmaceuticals and Ultragenyx are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Jazz Pharmaceuticals, https://bouncewatch.com/company/jazz-pharmaceuticals, updated 4 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes